Podcast
Dr. Randy Schatzman On Dodging Disruption: The New Fundraising Norm
Business of Biotech Podcast
Dr. Randy Schatzman On Dodging Disruption: The New Fundraising Norm
Business of Biotech Podcast
CMC Considerations For In-Human Studies with Drs. Edith Perez and Nathan Ihle
Business of Biotech Podcast
Randy Schatzman, PhD, CEO of Bolt Biotherapeutics
Biotech 2050 Podcast